One University of Kentucky researcher is working to develop new techniques for radiation treatment to improve survival rates of patients with a specific type of cancer.
The $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) will support research to understand how xylazine and fentanyl change the brain’s signaling pathways.
Ka-wing Fong, Ph.D., and Eric Rellinger, M.D., were named V Scholars by the V Foundation for Cancer Research and will each receive $600,000 to fund their individual cancer research projects.
Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.
One of the University of Kentucky Markey Cancer Center’s leading researchers has been selected to participate in the inaugural cohort of the National Institutes of Health (NIH) funded Institutional Development Award (IDeA) Regional Entrepreneurship Development (I-RED) Program.
The University of Kentucky has been selected as the nationwide coordination center for a National Institutes of Health (NIH) initiative, supported by a $3.4 million, five-year grant.
The University of Kentucky will be home to a new research center focused on tobacco regulations in the Commonwealth named the Appalachian Tobacco Regulatory Science Team (AppalTRuST).
